KALV vs LOW · rev $13.7M vs P/E 18, rev $49.03B
Kalvista Pharmaceuticals Inc (KALV) versus Lowe's Companies Inc (LOW) — a side-by-side from cached financials, not a winner call.
Kalvista Pharmaceuticals Inc (KALV) is a biotechnology company listed on NASDAQ.
Lowe's Companies Inc (LOW) is a home improvement retail company listed on NYSE.
Latest reported KALV revenue for 2025-09-30 was $13.7M. Net income was -$158.9M. KALV currently screens at market cap $1.44B.
Latest reported LOW revenue for 2026-07-31 was $49.03B. Net income was $4.03B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
KALV currently screens at market cap $1.44B. LOW currently screens at market cap $121.89B and trailing P/E 18.4.
Not investment advice. Open the KALV and LOW stock pages for the full models.
Not investment advice.